Graft-versus-host Disease
📧 Sign up to get email alerts when something new happens for Graft-versus-host Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval ·FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients
FDA approves TREGZI, the first regulatory T cell–based immunotherapy to improve chronic GVHD-free survival in adults undergoing allo-HSCT fo…